Markus Hoffmann
Impact in
- Infectious Diseases top 0.01%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Neurology top 0.1%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 71
- COVID-19 Clinical Research Studies 32
- Viral Infections and Outbreaks Research 16
- Viral Infections and Vectors 15
- SARS-CoV-2 detection and testing 13
- Epidemiology 30
- Virology and Viral Diseases 14
- Co-authors
- Stefan Pöhlmann (88 shared papers)Hannah Kleine‐Weber (10 shared papers)Nadine Krüger (25 shared papers)Christian Drosten (16 shared papers)Marcel A. Müller (12 shared papers)Georg Herrler (11 shared papers)Simon Schroeder (2 shared papers)Tanja Herrler (1 shared paper)
- Journals
- Journal of Virology (13 papers)PLoS ONE (8 papers)Cell Reports (7 papers)Viruses (6 papers)Cell (5 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Markus Hoffmann
115 papers receiving 18.8k citations
Markus Hoffmann's Hit Papers
Peers
Comparison fields: 5 of 179
- Infectious Diseases 13.2k
- Neurology 3.1k
- Obstetrics and Gynecology 908
- Animal Science and Zoology 1.1k
- Modeling and Simulation 410
Countries citing papers authored by Markus Hoffmann
This map shows the geographic impact of Markus Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hoffmann more than expected).
Fields of papers citing papers by Markus Hoffmann
This network shows the impact of papers produced by Markus Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hoffmann. The network helps show where Markus Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Hit paper breakdown → | 2020 | 13494 |
| 2 | A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Hit paper breakdown → | 2020 | 1232 |
| 3 | The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Hit paper breakdown → | 2021 | 566 |
| 4 | SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Hit paper breakdown → | 2021 | 566 |
| 5 | Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Hit paper breakdown → | 2020 | 390 |
| 6 | 2020 | 307 | |
| 7 | 2021 | 164 | |
| 8 | 2018 | 114 | |
| 9 | 2018 | 101 | |
| 10 | 2021 | 97 | |
| 11 | 2004 | 93 | |
| 12 | 2020 | 80 | |
| 13 | 2021 | 79 | |
| 14 | 2013 | 75 | |
| 15 | 2010 | 73 | |
| 16 | 2020 | 72 | |
| 17 | 2021 | 63 | |
| 18 | Characterization of 18F-FDG uptake in human endothelial cells in vitro. | 2004 | 62 |
| 19 | 2021 | 60 | |
| 20 | 2017 | 59 |
About Markus Hoffmann
Markus Hoffmann is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Animal Science and Zoology and Immunology, having authored 118 papers that have together received 19.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (71 papers), COVID-19 Clinical Research Studies (32 papers), Viral Infections and Outbreaks Research (16 papers), Animal Virus Infections Studies (16 papers), Viral Infections and Vectors (15 papers), Virology and Viral Diseases (14 papers), SARS-CoV-2 detection and testing (13 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Infectious Diseases (13.2k citations), Neurology (3.1k citations), Obstetrics and Gynecology (908 citations), Animal Science and Zoology (1.1k citations) and Modeling and Simulation (410 citations). Markus Hoffmann has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Stefan Pöhlmann, Hannah Kleine‐Weber, Nadine Krüger, Christian Drosten, Marcel A. Müller, Georg Herrler, Simon Schroeder, Tanja Herrler, Andreas Nitsche and Tobias S. Schiergens. Their work appears in journals such as Journal of Virology, PLoS ONE, Cell Reports, Viruses and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.